Clinical Liver Disease
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 111:15:50
- Mais informações
Informações:
Sinopse
Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.
Episódios
-
![16-3: Acute-on-Chronic Liver Failure: Which Definition is Appropriate in Latin America?]()
16-3: Acute-on-Chronic Liver Failure: Which Definition is Appropriate in Latin America?
25/10/2020 Duração: 09minAudible Article by Alberto Queiroz Farias, Paulo Lisboa Bittencourt
-
![16-3: Hepatitis E Virus Infection: Is It Really a Problem in Latin America?]()
16-3: Hepatitis E Virus Infection: Is It Really a Problem in Latin America?
25/10/2020 Duração: 09minAudible Article by Maria Belen Pisano, Santiago Mirazo, and Viviana E. Re
-
![16-3: Particularities of Autoimmune Hepatitis in Latin America]()
16-3: Particularities of Autoimmune Hepatitis in Latin America
25/10/2020 Duração: 09minAudible Article by Debora Terrabuio, Gilda Porta, and Eduardo Cancado
-
![16-3: Immunotherapy for Hepatocellular Carcinoma: Is Latin America Ready for Primetime?]()
16-3: Immunotherapy for Hepatocellular Carcinoma: Is Latin America Ready for Primetime?
25/10/2020 Duração: 09minAudible Article by Guillermo D. Mazzolini, Alexis Iracheta, Mariana Malvicini, and Juan Bayo
-
![16-3: Are We Really Taking Care of Alcohol-Related Liver Disease in Latin America]()
16-3: Are We Really Taking Care of Alcohol-Related Liver Disease in Latin America
25/10/2020 Duração: 09minAudible Article by Juan Pablo Arab, Ramon Bataller, and Juan Pablo Roblero
-
![16-3: The Importance of Knowing the Local Epidemiology When a Patient with Cirrhosis Acquires a Bacterial Infection]()
16-3: The Importance of Knowing the Local Epidemiology When a Patient with Cirrhosis Acquires a Bacterial Infection
25/10/2020 Duração: 09minAudible Article by Sebastian Marciano, Marcelo Valverde, Melisa Dirchwolf, Maria Nelly Gutierrez-Acevedo, and Adrian Gadano
-
![16-3: Impact of Herbal and Dietary Supplements Causing Drug-Induced Liver Injury in Latin America]()
16-3: Impact of Herbal and Dietary Supplements Causing Drug-Induced Liver Injury in Latin America
25/10/2020 Duração: 09minAudible Article by Vinicius Nunes and Nahum Mendez-Sanchez
-
![15-2: Development of Hepatocellular Carcinoma in Patients with Suppressed Viral Replication: Changes in Risk Over Time]()
15-2: Development of Hepatocellular Carcinoma in Patients with Suppressed Viral Replication: Changes in Risk Over Time
24/10/2020 Duração: 09minInterview with Prowpanga Udompap
-
![15-2: Graft-Versus-Host Disease After Liver Transplantation]()
15-2: Graft-Versus-Host Disease After Liver Transplantation
24/10/2020 Duração: 09minInterview with Christina C. Lindemeyer
-
![15-2: Treating Alcohol Use Disorder in Chronic Liver Disease]()
15-2: Treating Alcohol Use Disorder in Chronic Liver Disease
24/10/2020 Duração: 09minInterview with Eric Yoo
-
![15-2: Position 1: Transarterial Chemoembolization Should be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma]()
15-2: Position 1: Transarterial Chemoembolization Should be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma
24/10/2020 Duração: 09minInterview with Adam E. Mikolajczyk
-
![15-2: Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients with Cirrhosis Undergoing Liver Transplant Evaluation]()
15-2: Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients with Cirrhosis Undergoing Liver Transplant Evaluation
24/10/2020 Duração: 09minInterview with Catherine Frenette
-
![15-2: Optimizing Vaccination in Adult Patients with Liver Disease and Liver Transplantation]()
15-2: Optimizing Vaccination in Adult Patients with Liver Disease and Liver Transplantation
24/10/2020 Duração: 09minInterview with Yoona Rhee
-
![15-2: Parenteral Nutrition-Associated Liver Disease]()
15-2: Parenteral Nutrition-Associated Liver Disease
24/10/2020 Duração: 09minInterview with Kristen Nowak
-
![15-2: Development of Hepatocellular Carcinoma in Patients with Suppressed Viral Replication: Changes in Risk Over Time]()
15-2: Development of Hepatocellular Carcinoma in Patients with Suppressed Viral Replication: Changes in Risk Over Time
24/10/2020 Duração: 09minAudible Article by Prowpanga Udompap and W. Ray Kim
-
![15-2: Graft-Versus-Host Disease After Liver Transplantation]()
15-2: Graft-Versus-Host Disease After Liver Transplantation
24/10/2020 Duração: 09minAudible Article by Ashley Wood, Bijan Eghtesad, and Christina C. Lindemeyer
-
![15-2: Treating Alcohol Use Disorder in Chronic Liver Disease]()
15-2: Treating Alcohol Use Disorder in Chronic Liver Disease
24/10/2020 Duração: 09minAudible Article by Eric Yoo, George Cholankeril, and Aijaz Ahmed
-
![15-2: Position 2: Transarterial Chemoembolization Should be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma]()
15-2: Position 2: Transarterial Chemoembolization Should be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma
24/10/2020 Duração: 09minAudible Article by Syed Irfan-Ur Rahman, Laura Nunez-Herrero, and Jamie Lee Berkes
-
![15-2: Position 1: Transarterial Chemoembolization Should be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma]()
15-2: Position 1: Transarterial Chemoembolization Should be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma
24/10/2020 Duração: 09minAudible Article by Wasseem Skef, Mitali Agarwal, and Adam E. Mikolajczyk
-
![15-2: Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients with Cirrhosis Undergoing Liver Transplant Evaluation]()
15-2: Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients with Cirrhosis Undergoing Liver Transplant Evaluation
24/10/2020 Duração: 09minAudible Article by Leana Frankul and Catherine Frenette
